Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
67.9M
-
Shares change
-
+6.4M
-
Total reported value, excl. options
-
$3.24B
-
Value change
-
+$337M
-
Put/Call ratio
-
1.11
-
Number of buys
-
121
-
Number of sells
-
-64
-
Price
-
$47.75
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q4 2019
237 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2019.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.9M shares
.
Largest 10 shareholders include FMR LLC (8.83M shares), WELLINGTON MANAGEMENT GROUP LLP (7.96M shares), VANGUARD GROUP INC (5.61M shares), Capital International Investors (4.53M shares), Bellevue Group AG (3.92M shares), BlackRock Inc. (3.89M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.82M shares), GOLDMAN SACHS GROUP INC (2.29M shares), STATE STREET CORP (1.88M shares), and FIRST TRUST ADVISORS LP (1.53M shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.